SCHEMBL853701

SCHEMBL853701

CCCC(CC(=O)OCC)c1c[nH]c2ccc(OCc3ccccc3)cc12

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 3/20 0.55
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
LTA4H P09960 3/20 0.50
PLA2G2A P14555 3/20 0.50
HSP90AA1 P07900 1/20 0.50
HSP90AB1 P08238 1/20 0.50
GABRA1 P14867 2/20 0.48
GABRG2 P18507 2/20 0.48
GABRB3 P28472 2/20 0.48
GABRA5 P31644 2/20 0.48
GABRA3 P34903 2/20 0.48
GABRA2 P47869 2/20 0.48
HTR1D P28221 3/20 0.48
POLB P06746 1/20 0.46
KDM4E B2RXH2 2/20 0.45
MAPT P10636 2/20 0.45
SLC6A4 P31645 1/20 0.44
HPGD P15428 2/20 0.44
ALDH1A1 P00352 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL853777 0.82 GAA (0.43) MEN1KMT2AHTR1DKDM4EMAPT
SCHEMBL6219955 0.82 TRPM8 (0.60) TRPM8MEN1KMT2ALTA4HPLA2G2A
SCHEMBL6697020 0.81 ALDH1A1 (0.49) TRPM8MEN1KMT2ALTA4HPLA2G2A
SCHEMBL8387335 0.81 PKM (0.55) MEN1KMT2AGABRA1GABRG2GABRB3
SCHEMBL852664 0.79 KDM4E (0.41) KMT2AGABRA1GABRA3KDM4EMAPT
SCHEMBL20634172 0.79 TRPM8 (0.57) TRPM8MEN1KMT2ALTA4HPLA2G2A
SCHEMBL20634174 0.79 TRPM8 (0.57) TRPM8MEN1KMT2ALTA4HPLA2G2A
SCHEMBL20634163 0.79 TRPM8 (0.57) TRPM8MEN1KMT2ALTA4HPLA2G2A
SCHEMBL6219226 0.79 TRPM8 (0.70) TRPM8MEN1KMT2ALTA4HPLA2G2A
SCHEMBL6697085 0.77 ALDH1A1 (0.51) TRPM8MEN1KMT2ALTA4HPLA2G2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1425010-B8 SUBSTITUTED INDOLES AND THEIR USE AS INTEGRIN ANTAGONISTS JANSSEN PHARMACEUTICALS INC (US) 2012-03-28 EP disclosed
EP-1425010-A4 SUBSTITUTED INDOLES AND THEIR USE AS INTEGRIN ANTAGONISTS ORTHO MCNEIL PHARM INC (US) 2009-07-29 EP disclosed
EP-1425010-A1 SUBSTITUTED INDOLES AND THEIR USE AS INTEGRIN ANTAGONISTS Ortho-McNeil Pharmaceutical, Inc. (US) 2004-06-09 EP disclosed
WO-2002060438-A1 SUBSTITUTED INDOLES AND THEIR USE AS INTEGRIN ANTAGONISTS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2002-08-08 WO disclosed